Trinity’s 2025 Report Redefines Biopharma Digital Marketing Excellence

Trinity's 2025 Report shows a 19% increase in biopharma digital marketing maturity and patient engagement innovation.

Trinity, a global leader in life sciences commercialization, has published their 5th Annual TGaS Digital Marketing Competency Report, highlighting significant changes in the digital marketing practices in the biopharma world. This year's Everyday Digital Identity Marketers 2025 benchmark study of 150+ brands sees a 19% lift in "proficient" brands and an extraordinary acceleration toward digital maturity.

The report rates each brand using a scale of transformational to novice and evaluates more than 100 criteria relating to omnichannel execution, patient-centricity and digital innovation. Hemlibra (Genentech), Trelegy (GSK), Arexvy (GSK), Tezspire (Amgen & AstraZeneca), and Mavyret (AbbVie) are among the top examples of outstanding digital marketing success stories that have established a new benchmark for excellence in patient engagement.

In fact, the results indicate a whopping 112% increase in brands using Reddit as a vehicle for genuine, community-based interaction, structured in such a way that it points to a direction away from Facebook and Instagram hegemony. Further, DTC Access models are helping shape patient/caregiver relationships, strengthening the industry's emphasis on personalized interaction.

Jerry Luciano, Vice President of Omnichannel Marketing at Trinity, said, "Innovation in digital marketing in the life sciences is speeding up like never before." From awareness living to truly transformative and patient-centric engagement is what this industry is moving toward.

The report emphasizes that integration of digital marketing, data-driven customization and humane Germans and humans that link technology with experience are the cornerstones for smarter biopharma marketing moving forward.